Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Can Early Dissection of Cervical Lymph Nodes Improve Prognosis in Squamous Cell Carcinomas of the Hard Palate

Deneuve S.a · Bodard A.-G.a · Delquignies E.b · Janot F.b · Zrounba P.a · Julieron M.b

Author affiliations

aCentre Léon Bérard, Department of Surgical Oncology, Lyon, and bInstitut Gustave Roussy, Department of Head and Neck Surgery, Villejuif, France

Related Articles for ""

ORL 2017;79:314-322

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 22, 2017
Accepted: August 14, 2017
Published online: November 29, 2017
Issue release date: Published online first (Issue-in-Progress)

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 5

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL

Abstract

Squamous cell carcinomas of the hard palate and maxillary alveolar ridge are rare tumours with a poor prognosis. Lymph node dissection is recommended for tumours with nodal involvement, and is rarely performed in the absence of adenopathy. We report a series of patients with squamous cell carcinomas and evaluate the rate of lymph node invasion and its impact on survival. This is a retrospective study of 72 patients treated for squamous cell carcinoma of the hard palate and maxillary alveolar ridge between January 1, 1998 and December 31, 2008 in two cancer centres. Using clinical and radiological assessment, tumours were classified as T1-T2 in 25 patients (34.7%) and T3-T4 in 47 patients (65.3%). At diagnosis, 16 (22.2%) patients had clinical and/or radiological nodal involvement and 7 patients (9.7%) distal metastasis. Among N0 patients, 13 (18%) experienced isolated lymph node recurrence. Two-year global survival was 60%; 5-year survival was 34%. The rate of lymph node invasion observed in squamous cell carcinoma of the hard palate and maxillary alveolar ridge does not differ from other oral cavity sites. Because nodal recurrence worsens the prognosis of such a patient, lymph node dissection should be considered at an early stage, even among N0 patients.

© 2017 S. Karger AG, Basel


References

  1. Simental A, Myers E: Cancer of the hard palate and maxillary alveolar ridge: technique and applications. Oper Tech Otolaryngol 2005;16:28-35.
    External Resources
  2. Petruzzelli GJ, Myers EN: Malignant neoplasms of the hard palate and upper alveolar ridge. Oncology (Williston Park) 1994;8:43-48; discussion 50, 53.
    External Resources
  3. Kruse AL Gratz KW: Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years. Head Neck Oncol 2009;1:28.
  4. Simental AA Jr, Johnson JT, Myers EN: Cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate. Laryngoscope 2006;116:1682-1684.
  5. Werner J, Dunne A, Myers JN: Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck 2003;25:322-332.
  6. Layland MK, Sessions DG, Lenox J: The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115:629-639.
  7. Kowalski LP Sanabria A: Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol Ital 2007;27:113-117.
    External Resources
  8. Wang Y, Ow TJ, Myers JN: Pathways for cervical metastasis in malignant neoplasms of the head and neck region. Clin Anat 2012;25:54-71.
  9. Lim YC, Koo BS, Lee JS, Lim JY, Choi EC: Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck. Laryngoscope 2006;116:1148-1152.
  10. Hiratsuka H, Miyakawa A, Nakamori K, Kido Y, Sunakawa H, Kohama G: Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 1997;80:351-356.
  11. Hao SP, Tsang NM: The role of supraomohyoid neck dissection in patients of oral cavity carcinoma. Oral Oncol 2002;38:309-312.
  12. Shah J, Candela F, Poddar A: The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990;66:109-113.
  13. Zbären P, Muyens M, Caversaccio M, Stauffer E: Elective neck dissection for carcinomas of the oral cavitiy: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive nodes. Am J Surg 2006;191:756-760.
  14. Wang T, Hua CH, Lin CC, Tsou YA, Tseng HC, Tsai MH: Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:11-17.
  15. Morris LG, Patel SG, Shah JP, Ganly I: High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus. Head Neck 2011;33:824-830.
  16. Mourouzis C, Pratt C, Brennan P: Squamous cell carcinoma of the maxillary gingiva, alveolus and hard palate: is there a need for elective neck dissection? Br J Oral Maxillofac Surg 2010;48:345-348.
  17. Beltramini GA, Massarelli O, Demarchi M, Copelli C, Cassoni A, Valentini V, Tullio A, Gianni AB, Sesenna E, Baj A: Is neck dissection needed in squamous-cell carcinoma of the maxillary gingiva, alveolus, and hard palate? A multicentre Italian study of 65 cases and literature review. Oral Oncol 2012;48:97-101.
  18. Yang Z, Deng R, Sun G, Huang X, Tang E: Cervical metastases from squamous cell carcinoma of hard palate and maxillary alveolus: a retrospective study of 10 years. Head Neck 2014;36:969-975.
  19. Xu Y, Lefèvre M, Périé S, Tao L, Callard P, Bernaudin JF, St Guily JL: Clinical significance of micrometastases detection in lymph nodes from head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2008;138:436-441.
  20. Ferlito A, Rinaldo A, Devaney KO, Nakashiro K, Hamakawa H: Detection of lymph node micrometastasis in patients with squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2008;2656:1147-1153.
  21. Hermanek P, Hutter RV, Sobin LH, Wittekind C: International Union against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
  22. Hamakawa H, Takemura K, Sumida T: Histological study on pN upgrading of oral cancer. Virchows Arch 2000;437:116-121.
  23. Nieuwenhuis E, Leemans C, Kummer J: Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6F) quantitative reverse transcription-polymerase chain reaction. Lab Invest 2003;83:1233-1240.
  24. Jeong HS, Baek CH, Son YI, Ki Chung M, Kyung Lee D, Young Choi J, Kim BT, Kim HJ: Use of integrated 18-F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:203-210.
  25. Lin H, Bhattacharyya N: Survival impact of nodal disease in hard palate and maxillary alveolus cancer. Laryngoscope 2009;119:312-315.
  26. Lim YC, Lee JS, Choi EC: Perifacial lymph node metastasis in the submandibular triangle of patients with oral and oropharyngeal squamous cell carcinoma with clinically node-positive neck. Laryngoscope 2006;116:2187-2190.
  27. Lengelé B, Hamoir M, Scalliet P, Grégoire V: Anatomical bases for the radiological delineation of lymph node areas. Major collecting trunks, head and neck. Radiother Oncol 2007;85:146-155.
  28. Givi B, Eskander A, Awad MI, Kong Q, Montero PH, Palmer FL, Xu W, De Almeida JR, Lee N, O'Sullivan B, Irish JC, Gilbert R, Ganly I, Patel SG, Goldstein DP, Morris LG: Impact of elective neck dissection on the outcome of oral squamous cell carcinomas arising in the maxillary alveolus and hard palate. Head Neck 2016;38(suppI 1):1588-1694.
  29. Binhamed A, Nason RW, Hussain A, Abdoh AA, Sándor GK: Treatment outcomes in squamous cell carcinoma of the maxillary alveolus and palate: a population-based study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:750-754.
  30. Yokoo S, Umeda M, Komatsubara H, Shibuya Y, Komori T: Evaluation of T-classifications of upper gingival and hard palate carcinomas - a proposition for new criterion of T4. Oral Oncol 2002;38:378-382.
  31. Sasaki T, Imai Y, Fujibayashi T: New proposal for T classification of gingival carcinomas arising in the maxilla. Int J Oral Maxillofac Surg 2004;33:349-352.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 22, 2017
Accepted: August 14, 2017
Published online: November 29, 2017
Issue release date: Published online first (Issue-in-Progress)

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 5

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.